Logo image of PHIO

PHIO PHARMACEUTICALS CORP (PHIO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PHIO - US71880W5013 - Common Stock

1.09 USD
+0.01 (+0.93%)
Last: 1/23/2026, 8:00:00 PM
1.1 USD
+0.01 (+0.92%)
After Hours: 1/23/2026, 8:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PHIO. PHIO was compared to 525 industry peers in the Biotechnology industry. While PHIO seems to be doing ok healthwise, there are quite some concerns on its profitability. PHIO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year PHIO has reported negative net income.
  • In the past year PHIO has reported a negative cash flow from operations.
  • In the past 5 years PHIO always reported negative net income.
  • In the past 5 years PHIO always reported negative operating cash flow.
PHIO Yearly Net Income VS EBIT VS OCF VS FCFPHIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • PHIO has a Return On Assets of -69.13%. This is in the lower half of the industry: PHIO underperforms 62.10% of its industry peers.
  • The Return On Equity of PHIO (-80.83%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -69.13%
ROE -80.83%
ROIC N/A
ROA(3y)-110.57%
ROA(5y)-88.07%
ROE(3y)-133.2%
ROE(5y)-105.54%
ROIC(3y)N/A
ROIC(5y)N/A
PHIO Yearly ROA, ROE, ROICPHIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

1.3 Margins

  • PHIO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHIO Yearly Profit, Operating, Gross MarginsPHIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20K -40K -60K

6

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, PHIO has more shares outstanding
  • Compared to 5 years ago, PHIO has more shares outstanding
  • There is no outstanding debt for PHIO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PHIO Yearly Shares OutstandingPHIO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
PHIO Yearly Total Debt VS Total AssetsPHIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • PHIO has an Altman-Z score of -15.77. This is a bad value and indicates that PHIO is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of PHIO (-15.77) is worse than 80.00% of its industry peers.
  • PHIO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -15.77
ROIC/WACCN/A
WACCN/A
PHIO Yearly LT Debt VS Equity VS FCFPHIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 6.90 indicates that PHIO has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 6.90, PHIO is in the better half of the industry, outperforming 69.52% of the companies in the same industry.
  • A Quick Ratio of 6.90 indicates that PHIO has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 6.90, PHIO is doing good in the industry, outperforming 69.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.9
Quick Ratio 6.9
PHIO Yearly Current Assets VS Current LiabilitesPHIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 81.87% over the past year.
EPS 1Y (TTM)81.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, PHIO will show a very strong growth in Earnings Per Share. The EPS will grow by 23.91% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y75.37%
EPS Next 2Y35.74%
EPS Next 3Y23.91%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PHIO Yearly Revenue VS EstimatesPHIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2023 20M 40M 60M
PHIO Yearly EPS VS EstimatesPHIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -50K -100K -150K

1

4. Valuation

4.1 Price/Earnings Ratio

  • PHIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year PHIO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PHIO Price Earnings VS Forward Price EarningsPHIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PHIO Per share dataPHIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as PHIO's earnings are expected to grow with 23.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.74%
EPS Next 3Y23.91%

0

5. Dividend

5.1 Amount

  • PHIO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

PHIO PHARMACEUTICALS CORP / PHIO FAQ

Can you provide the ChartMill fundamental rating for PHIO PHARMACEUTICALS CORP?

ChartMill assigns a fundamental rating of 2 / 10 to PHIO.


What is the valuation status for PHIO stock?

ChartMill assigns a valuation rating of 1 / 10 to PHIO PHARMACEUTICALS CORP (PHIO). This can be considered as Overvalued.


What is the profitability of PHIO stock?

PHIO PHARMACEUTICALS CORP (PHIO) has a profitability rating of 0 / 10.


How financially healthy is PHIO PHARMACEUTICALS CORP?

The financial health rating of PHIO PHARMACEUTICALS CORP (PHIO) is 6 / 10.